SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-20-003925
Filing Date
2020-05-05
Accepted
2020-05-05 16:16:30
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1865906
2 filename2.htm EX-3.1 115903
3 filename3.htm EX-3.3 135739
4 filename4.htm EX-4.1 186412
5 filename5.htm EX-21.1 2456
6 GRAPHIC g913838g02k21.jpg GRAPHIC 52785
7 GRAPHIC g913838g15i24.jpg GRAPHIC 124155
8 GRAPHIC g913838g15y33.jpg GRAPHIC 119003
9 GRAPHIC g913838g26b42.jpg GRAPHIC 83271
10 GRAPHIC g913838g30q65.jpg GRAPHIC 107350
11 GRAPHIC g913838g31a64.jpg GRAPHIC 130953
12 GRAPHIC g913838g41b13.jpg GRAPHIC 70998
13 GRAPHIC g913838g70w93.jpg GRAPHIC 130900
14 GRAPHIC g913838g83v36.jpg GRAPHIC 122299
15 GRAPHIC g913838g87v36.jpg GRAPHIC 106021
16 GRAPHIC g913838g88c12.jpg GRAPHIC 102808
17 GRAPHIC g913838g92b36.jpg GRAPHIC 122885
18 GRAPHIC g913838g94e38.jpg GRAPHIC 112627
  Complete submission text file 0000950123-20-003925.txt   4218504
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03152 | Film No.: 20849070
SIC: 2834 Pharmaceutical Preparations